METASTATIC COLORECTAL ADENOCARCINOMA
Clinical trials for METASTATIC COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine targets tough cancers in early trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study is testing a personalized vaccine made from a patient's own tumor cells and blood. The goal is to see if it's safe and possible to create and give this vaccine to people with advanced pancreatic or colorectal cancer that has spread. About 300 adults with th…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:53 UTC
-
New pill shows promise in early trial for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new oral medication, PF-08032562, in people with advanced breast or colorectal cancer that has spread. The goal is to find the safest dose and see if it works alone or with other cancer treatments. About 260 adults will take the pill daily in 28-day…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
Radio waves plus drug may extend life in tough-to-treat colon cancer
Disease control Recruiting nowThis study tests whether adding a non-invasive radiofrequency treatment (AM RF EMF) to the drug fruquintinib can help people with metastatic colorectal cancer that has stopped responding to standard therapies. About 102 adults will receive both treatments to see if it improves su…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New combo attack: fasting diet plus vitamin c may boost immunotherapy in tough colorectal cancer
Disease control Recruiting nowThis early-phase study is testing whether adding a fasting-mimicking diet and high-dose vitamin C to two immunotherapy drugs (botensilimab and balstilimab) is safe and effective for people with a specific type of advanced colorectal cancer (KRAS-mutant). The diet is low in calori…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New trial zaps and cuts colorectal cancer spots to boost survival
Disease control Recruiting nowThis study is for people with colorectal cancer that has spread to up to 4 places in the body. It compares standard drug therapy alone versus standard therapy plus focused radiation, surgery, or heat-based tumor destruction. The goal is to see if adding these local treatments hel…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug combo hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a combination of two drugs—trifluridine/tipiracil (a chemotherapy) and talazoparib (a targeted therapy)—in people with advanced colorectal or gastroesophageal cancers that have spread. The main goals are to find the safest dose and understand side eff…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for Tough-to-Treat colorectal cancer: drug combo trial launches
Disease control Recruiting nowThis study is for people with advanced colorectal cancer that no longer responds to standard treatments. It tests a combination of two drugs: pidnarulex, which blocks enzymes that help cancer cells grow, and cemiplimab, an immunotherapy that helps the immune system attack cancer.…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New combo therapy aims to boost colorectal cancer treatment
Disease control Recruiting nowThis early-phase trial tests a new drug called CA-4948 added to standard chemotherapy (FOLFOX) and a targeted therapy (bevacizumab) for people with colorectal cancer that has spread and cannot be removed by surgery. The main goals are to find the best dose and check for side effe…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC